Congress

09:00 - 09:15
Unveiling PACAP's role in migraine: Evidence from human provocation studies

MESSOUD ASHINA

Speaker

09:15 - 09:30
Decoding PACAP signalling: Splice variants, pathways, and designer drugs

DEBBIE HAY

Speaker

09:30 - 09:45
Can PACAP activate meningeal nociceptors?

RUNE HÄCKERT CHRISTENSEN

Speaker

09:45 - 10:00
PACAP vs. CGRP: Unveiling migraine mechanisms through mouse models

ANDREW RUSSO

Speaker

10:00 - 10:15
Profiling non-responders and super-responders to anti-CGRP treatment

UWE REUTER

Speaker

10:15 - 10:30
Clinical features and biomarkers predicting treatment response in migraine

GISELA TERWINDT

Speaker

10:30 - 10:45
Role of central sensitisation and interictal allodynia

SAIT ASHINA

Speaker

10:45 - 11:00
Molecular biomarkers and migraine treatment response

PATRICIA POZO-ROSICH

Speaker

08:00 - 08:20
Different kinds of migraine triggers are reported in different parts of the world

TSUBASA TAKIZAWA

Speaker

08:20 - 08:40
The hypothalamus: Conductor of the migraine prodrome

TODD SCHWEDT

Speaker

08:40 - 09:00
Is the hypothalamus to blame? Rethinking its role in the migraine prodrome

HAKAN ASHINA

Speaker

09:00 - 09:25
From Patterns to Precision: Big Data and AI in Headache Conditions

ERLING TRONVIK

Speaker

09:25 - 09:50
AI-Driven Innovations in the Migraine field – from neural networks to networked care

ALEXANDRE DASILVA

Speaker

09:50 - 10:00
Discussion

10:00 - 10:20
Deciphering the mechanisms: Pathophysiology of migraine-related cognitive dysfunction

RAQUEL GIL-GOUVEIA

Speaker

10:20 - 10:40
Cognitive impairments in primary and secondary headache disorders

MATTHEW ROBBINS

Speaker

10:40 - 11:00
Migraine and cognitive decline

MANJIT MATHARU

Speaker

13:00 - 13:20
Shared genetics and causal relationships between migraine and its comorbidities

DALE NYHOLT

Speaker

13:20 - 13:40
Genetic susceptibility of migraine endophenotypes across ethnicities

SHIH-PIN CHEN

Speaker

13:40 - 14:00
Mapping out neurons that contribute to headache (USA)

WILL RENTHAL

Speaker

13:00 - 13:15
Facial trigeminal autonomic cephalalgias (TACs)

ARNE MAY

Speaker

13:15 - 13:30
Low face migraine

RAFAEL BENOLIEL

Speaker

13:30 - 13:45
Facial tension type headache

PAULO CONTI

Speaker

13:45 - 14:00
Optimising combined treatment for migraine and temporomandibular disorders

MARCELA ROMERO REYES

Speaker

13:00 - 13:20
The biology and genetics of childhood and adolescent migraine: Why the prevalence is similar in childhood but different in adolescence

ANDREW HERSHEY

Speaker

13:20 - 13:40
Mitochondrial Stress Response and Effects in Migraine Pathophysiology

HAYRUNNISA BOLAY

Speaker

13:40 - 14:00
Impact of co-morbidity, resilience, and vulnerability on childhood and adolescent headaches

MARCO ARRUDA

Speaker

14:00 - 14:15
Migraine multidisciplinary approach in family medicine

SUSAN HUTCHINSON

Speaker

14:15 - 14:30
Exclusion of important life-threatening causes of headache

HENRIK SCHYTZ

Speaker

14:30 - 14:45
Managing primary headache disorders in a primary headache care setting

AYNUR ÖZGE

Speaker

14:45 - 15:00
Discussion

14:00 - 14:15
Migraine with and without aura are distinct disorders

MARGARITA SÁNCHEZ DEL RÍO

Speaker

14:15 - 14:30
CSD provides a common therapeutic target for widely prescribed migraine prophylactic drugs and neuromodulation devices

ANNA ANDREOU

Speaker

14:30 - 14:45
Brain imaging in migraine with and without aura: Similarities and differences

GIANLUCA COPPOLA

Speaker

14:45 - 15:00
Discussion

14:00 - 14:15
Early attack treatment: decoding the migraine prodrome

EDOARDO CARONNA

Speaker

14:15 - 14:30
Early prevention: Disease prevention or prevention of disease progression?

RAMI BURSTEIN

Speaker

14:30 - 14:45
What do the guidelines say?

CRISTINA TASSORELLI

Speaker

14:45 - 15:00
Discussion

14:00 - 14:15
Advocating for Therapeutic Approaches Targeting Elevated Pressure States

ALEXANDRA SINCLAIR

Speaker

14:15 - 14:30
Imagine pearls in the diagnosis of intracranial hyper- and hypo-tension associated with headache

LASZLO MECHTLER

Speaker

14:30 - 14:45
Proposing management strategies tailored to addressing intracranial hypotension

MARCIO NATTAN

Speaker

14:45 - 15:00
Discussion

15:00 - 15:15
Sex differences in response to triptans

ANTOINETTE MAASSEN VAN DEN BRINK

Speaker

15:15 - 15:30
Pain behaviours to CGRP and other neuropeptides – sex differences?

GREG DUSSOR

Speaker

15:30 - 15:45
Evaluation of outcomes of CGRP-targeting therapies for acute and preventive migraine treatment based on patient sex

DAVID DODICK

Speaker

15:45 - 16:00
Is there a gender difference in the response to onabotulinumtoxinA or CGRP inhibitors in chronic migraine?

SIMONA SACCO

Speaker

16:15 - 16:30
Migraine and TMD: Exploring the Role of CGRP in Their Overlapping Mechanisms

DANIELA APARECIDA DE GODOI GONÇALVES

Speaker

16:30 - 16:45
From Acute to Chronic: What Do We Know About Orofacial Pain Progression and Headache Involvement?

ANA MIRIAM VELLY

Speaker

16:45 - 17:00
TMD Myalgia and Headache: Pathophysiological Mechanisms and Clinical Implications

SIMON AKERMAN

Speaker

17:00 - 17:15
Discussion

16:15 - 16:30
Circadian features of headache disorders – can we explain why?

MARK BURISH

Speaker

SEUNG-HEE YOO

Speaker

16:30 - 16:45
Genetics and chronobiology of cluster headache - what does it teach me about the pathophysiology

ANDREA CARMINE BELIN

Speaker

16:45 - 17:00
Chronobiology of cluster headache attacks – my proposed explanation

MIJI LEE

Speaker

17:00 - 17:15
Discussion

16:15 - 16:30
Global disparities in migraine care: A call for universal access to diagnosis and treatment

MARIO PERES

Speaker

16:30 - 16:45
Regional variations in headache burden

YARED Z. ZEWDE

Speaker

16:45 - 17:00
What did I learn from the field in LMIC? What did I bring from the metropolis to the field?

DERYA ULUDÜZ

Speaker

17:00 - 17:15
Discussion

16:15 - 16:30
Migraine – a borderland disease to epilepsy: Near it but not of it

CHRISTIAN LAMPL

Speaker

16:30 - 16:45
Pathophysiology of ictal and post-ictal headache

PIERO BARBANTI

Speaker

16:45 - 17:00
Migraine and idiopathic epilepsies comorbidity

ESME EKIZOĞLU-TURGUT

Speaker

17:00 - 17:15
Migraine and epilepsy: From bench to bedside

ELSE TOLNER

Speaker

16:15 - 16:30
Scientific rationale for polytherapy

AGUSTIN MELO-CARRILLO

Speaker

16:30 - 16:45
Acute treatment of migraine: When one drug is not enough

RICHARD LIPTON

Speaker

16:45 - 17:00
Experiences with dual therapy with onabotulinumtoxinA and CGRP antibodies: Real world evidence data

FAISAL MOHAMMAD AMIN

Speaker

17:00 - 17:15
Discussion

09:00 - 09:15
Understanding the pathogenesis of cluster headache in the CGRP era: Where are we?

ROBERTO DE ICCO

Speaker

09:15 - 09:30
Do pathophysiological differences exist between episodic and chronic cluster headache?

PHILIP HOLLAND

Speaker

09:30 - 09:45
Clinical response prediction of approved anti-CGRP in the prevention of cluster headache and what is next

MONA NADA

Speaker

09:45 - 10:00
Discussion

09:00 - 09:15
Decoding the aura table: Unveiling visual disturbances and perception in migraine auras

MICHELE VIANA

Speaker

09:15 - 09:30
Beyond the scan: Exploring neuroimaging and the quest for objective documentation of migraine aura phenomena

NOUCHINE HADJIKHANI

Speaker

09:30 - 09:45
Initiation and propagation of spreading depolarisation: Considerations for migraine

K C BRENNAN

Speaker

09:45 - 10:00
Discussion

09:00 - 09:15
Update on pharmacological options currently available for the treatment of migraine in children and adolescents

CHRISTINA L SZPERKA

Speaker

09:15 - 09:30
Does controlling migraine improve interictal cognition in children and adolescents? Does more need to be done?

MASSIMILIANO VALERIANI

Speaker

09:30 - 09:45
What are the key messages for the non-pharmacological approach of migraine in children and adolescents?

SERENA ORR

Speaker

09:45 - 10:00
Discussion

09:00 - 09:15
Transcranial direct current stimulation (tDCS)

MICHAEL NITSCHE

Speaker

09:15 - 09:30
Transcranial magnetic stimulation (TMS)

FELIPE FREGNI

Speaker

09:30 - 09:45
Peripheral nerve stimulation

MAROM BIKSON

Speaker

09:45 - 10:00
Discussion

14:30 - 14:50
VSS is a form of migraine aura–overlapping clinical features, neurophysiology, and neuroimaging

CHRISTOPH SCHANKIN

Speaker

14:50 - 15:10
Visual snow vs. migraine aura

PETER GOADSBY

Speaker

15:10 - 15:30
Debate summary and novel insights into the syndrome

FRANCESCA PULEDDA

Speaker

14:30 - 14:50
Sex and hormonal influences on migraine pain – the science

ANDREA HARRIOTT

Speaker

14:50 - 15:10
CGRP, onabotulinumtoxinA, and others. Are they safe?

FAYYAZ AHMED

Speaker

15:10 - 15:30
Addressing migraine in the breastfeeding period: Practical approaches for primary care providers

FABIOLA DACH

Speaker

14:30 - 14:45
Demystifying trigeminal neuropathic pain in the face and mouth - guidelines on diagnosis, treatment, and follow-up care

TARA RENTON

Speaker

14:45 - 15:00
The Surgeon's Role in Managing Trigeminal and Occipital Neuropathic Pain

PAMELA BLAKE

Speaker

15:00 - 15:15
Neuromodulation procedures for trigeminal neuralgia – the science behind

PARAG PATIL

Speaker

15:15 - 15:30
The role of tumours in headaches and neuralgias – the perspective from neurosurgery

MARCELO VALENCA

Speaker

14:30 - 14:50
Telemedicine as a solution for headaches in LMIC countries

NAJIB KISSANI

Speaker

14:50 - 15:10
Partnership, education and care to improve the management of headaches in sub-Saharan Africa

MASSIMO LEONE

Speaker

15:10 - 15:30
Community Pharmacists in Headache Management: Expanding the Scope

HEBA BANI HANI

Speaker

15:30 - 15:45
Discussion

16:00 - 16:20
Non-paralytic botulinum toxins for the treatment of headaches and pain

BAZBEK DAVLETOV

Speaker

16:20 - 16:40
Anti-nociceptive activities of novel long-acting SNARE-inactivating biotherapeutics

JIAFU WANG

Speaker

16:40 - 17:00
Navigated injections with botulinum toxin A towards the sphenopalatine ganglion: a randomized, placebo-controlled trial in chronic migraine patients

TORE MEISINGSET

Speaker